Master
Media Component
Content
Entering its third decade, Texas Children’s Hospital Center for Vaccine Development is recognized globally for advancing vaccines against poverty-related neglected and emerging infectious diseases (NTDs).
The Center aims to lead the development and testing of affordable, effective vaccines and immunotherapies for emerging and neglected tropical diseases. Its mission is two-fold: to create and test these vaccines and therapies, and to build local and international capacity for vaccine development.
The following achievements highlight the work at the Vaccine Center:
- Developed a COVID-19 vaccine that was administered over 100 million times in India and Indonesia. Developed vaccines for emerging coronavirus infections: Severe Acute Respiratory Syndrome (SARS) and Middle-East Respiratory Syndrome (MERS).
- Developed the first vaccine for human hookworm infection, now in clinical trials.
- Developed the first vaccine for intestinal schistosomiasis, now in clinical trials.
- Developed the first vaccine for Chagas disease, now inclinical trials.
- Established a portfolio of early stage vaccines against other major soil-transmitted helminths, onchocerciasis, and leishmaniasis.
Heading
Center Co-Directors
People
First Name
Peter
Middle Name
Jay
Last Name
Hotez
Honorific Title
M.D., Ph.D.
Dean for the National School of Tropical Medicine
First Name
Maria
Middle Name
Elena
Last Name
Bottazzi
Honorific Title
Ph.D.
Sr. Associate Dean, National School of Tropical Medicine
